1,544
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Methamphetamine use in Melbourne, Australia: baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence

, , &
Pages 349-362 | Published online: 19 Apr 2012

References

  • Aitken, C., Brough, R., & Crofts, N. (1999). Injecting drug use and blood-borne viruses: A comparison of rural and urban Victoria, 1990–95. Drug and Alcohol Review, 18, 47–52.
  • Australian Bureau of Statistics.(2001). Information paper: Use of the Kessler Psychological Distress Scale in ABS health surveys, Australia. Canberra: Author.
  • Australian Crime Commission.(2010). Illicit drug data report: 2008–09. Canberra: Author.
  • Australian Crime Commission.(2011). Illicit drug data report: 2009–10. Canberra: Author.
  • Australian Institute of Health and Welfare.(2010). Alcohol and other drug treatment services in Australia 2008–09: Report on the National Minimum Data Set. Canberra: Author.
  • Australian Institute of Health and Welfare.(2011). 2010 National drug strategy household survey report. Canberra: Author.
  • Baker, A., Boggs, T. G., & Lewin, T. J. (2001a). Characteristics of regular amphetamine users and implications for treatment. Drug and Alcohol Review, 20, 49–56.
  • Baker, A., Boggs, T. G., & Lewin, T. J. (2001b). Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine. Addiction, 96, 1279–1287.
  • Baker, A., & Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist, 40(2), 88–95.
  • Brecht, M. L., O’Brien, A., von Mayrhauser, C., & Anglin, M. D. (2004). Methamphetamine use behaviors and gender differences. Addictive Behaviors, 29(1), 89–106.
  • Bush, K., Kivlahan, D. R., McDonnell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives of Internal Medicine, 158, 1789–1795.
  • Christian, D. R., Huber, A., Brecht, M. L., McCann, M. J., Marinelli-Casey, P., Lord, R. H., Reiber, C., Lu, T. H., The Methamphetamine Treatment Project, , Galloway, G. P.. (2007). Methamphetamine users entering treatment: Characteristics of the methamphetamine treatment project sample. Substance Use & Misuse, 42, 2207–2222.
  • Cogger, S., McKetin, R., Ross, J., & Najman, J. (2008). Methamphetamine Treatment Evaluation Study (MATES): Findings from the Brisbane site. Sydney: National Drug and Alcohol Research Centre.
  • Darke, S., & Hall, W. (1995). Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug and Alcohol Dependence, 89, 1683–1690.
  • Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction, 87, 733–742.
  • Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 253–262.
  • Deady, M. (2009). A Review of screening, assessment and outcome measures for drug and alcohol settings. Strawberry Hills: Network of Alcohol & other Drug Agencies (NADA).
  • Degenhardt, L., Baker, A., & Maher, L. (2008a). Methamphetamine: Geographic areas and populations at risk, and emerging evidence for effective interventions (editorial). Drug and Alcohol Review, 27(3), 217–219.
  • Degenhardt, L., Mathers, B., Guarinieri, M., Panda, S., Phillips, B., Strathdee, S. A., Tyndall, M., Wiessing, L., Wodak, A., . (2007). The global epidemiology of methamphetamine injection: A review of the evidence on use and associations with HIV and other harm. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  • Degenhardt, L., Roxburgh, A., Black, E., Bruno, R., Campbell, G., Kinner, S., Fetherston, J., . (2008b). The epidemiology of methamphetamine use and harm in Australia. [Research Support, Non-U.S. Gov’t Review]. Drug and Alcohol Review, 27(3), 243–252.
  • Feigin, A., Dietze, P., & Lloyd, B. (2011). Victorian trends in ecstasy and related drug markets 2010: Findings from the Ecstasy and related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  • Fry, C. L., Hall, W., Ritter, A., & Jenkinson, R. (2006). The ethics of paying drug users who participate in research: A review and practical recommendations. Journal of Empirical Research on Human Research Ethics, 1(4), 21–36.
  • Gaffney, A., Jones, W., Sweeney, J., & Payne, J. (2010). Drug use monitoring in Australia: 2008 annual report on drug use among police detainees. Canberra: Australian Institute of Criminology.
  • Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., Strang, J., (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.
  • Greenwell, L., & Brecht, M. (2003). Self-reported health status among treated methamphetamine users. American Journal of Drug and Alcohol Abuse, 29(1), 75–104.
  • Hando, J., Topp, L., & Hall, W. (1997). Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence, 46, 105–113.
  • Hayatbakhsh, M. R., Najman, J. M., Bor, W., & Williams, G. M. (2009). Predictors of young adults’ amphetamine use and disorders: A prospective study. [Research Support, Non-U.S. Gov’t]. Drug and Alcohol Review, 28(3), 275–283.
  • Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174–199.
  • Johnston, J., Laslett, A.-M., Miller, P., Jenkinson, R., Fry, C., & Dietze, P. (2004). Victorian psychostimulant monitoring project: Trialling enhanced drug trend monitoring of Melbourne psychostimulant markets (final report). Fitzroy: Turning Point Alcohol and Drug Centre.
  • Kelly, E., McKetin, R., & McLaren, J. (2005). Health service utilisation among regular methamphetamine users. Sydney: NDARC.
  • Kenny, P., Harney, A., Lee, N. K., & Pennay, A. (2011). Treatment utilization and barriers to treatment: Results of a survey of dependent methamphetamine users. Substance Abuse, Treatment, Prevention, and Policy, 6(3), 1–7.
  • Kessler, R. C. (1996). Kessler Psychological Distress Scale (K10). Boston, MA: Harvard Medical School.
  • Klee, H., & Morris, J. (1994). Factors that lead young amphetamine misusers to seek help: Implications for drug prevention and harm reduction. Drugs: Education, Prevention and Policy, 1(3), 289–297.
  • Klee, H., Wright, S., & Morris, J. (1999). Amphetamine users in treatment: Factors associated with sustained abstinence from street drugs. Addiction Research, 7(3), 239–265.
  • Macgregor, S., & Payne, J. (2011). Findings from the DUMA program: Increase in use of methamphetamine. Canberra: Australian Institute of Criminology.
  • McKetin, R., & Kelly, E. (2007). Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug and Alcohol Review, 26, 161–168.
  • McKetin, R., Kelly, E., & McLaren, J. (2006a). The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence, 85, 198–204.
  • McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006b). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101(10), 1473–1478.
  • McKetin, R., Kelly, E., McLaren, J., & Proudfoot, H. (2008a). Impaired physical health among methamphetamine users in comparison with the general population: The role of methamphetamine dependence and opioid use. Drug and Alcohol Review, 27(5), 482–489.
  • McKetin, R., Ross, J., Kelly, E., Baker, A., Lee, N., Lubman, D. I., Mattick, R., (2008b). Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug and Alcohol Review, 27(3), 277–285.
  • McKetin, R., McLaren, J., & Kelly, E. (2005a). The dynamics of the Sydney methamphetamine market: An overview of supply, use patterns, harms and social consequences. Adelaide: Australasian Centre for Policing Research.
  • McKetin, R., McLaren, J., & Kelly, E. (2005b). The Sydney methamphetamine market: Patterns of supply, use, personal harms and social consequences. Sydney: National Drug and Alcohol Research Centre, University of NSW.
  • McKetin, R., McLaren, J., Kelly, E., Hall, W., & Hickman, M. (2005c). Estimating the number of regular and dependent methamphetamine users in Australia. Sydney: NDARC, UNSW.
  • McKetin, R., Sutherland, R., Ross, J., Najman, J., Mamun, A., Baker, A., Mattick, R., Rosenfield, J., (2010). Methamphetamine Treatment Evaluation Study (MATES): Three-year outcomes from the Sydney site. Sydney: NDARC, UNSW.
  • Reddel, S. E., Horyniak, D., Dietze, P., & McElwee, P. (2011). Victorian Drug Trends 2010: Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  • Ross, J., & Miller, S. (1994). Hidden use of amphetamine in metropolitan Melbourne. In R. Godding & G. Whelan (Eds.), Proceedings of the 1994 autumn school of studies on alcohol and drugs (pp. 49–52). Melbourne: Department of Drug and Alcohol Studies, St Vincent’s Hospital.
  • Sindicich, N., & Burns, L. (2011). Australian trends in ecstasy and related drug markets 2010: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  • Stafford, J., & Burns, L. (2011). Australian drug trends 2010: Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  • Topp, L., & Mattick, R. P. (1997). Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction, 92, 839–845.
  • United Nations Office on Drugs and Crime.(2011). Amphetamines and ecstasy: 2011 global ATS assessment. Vienna: Author.
  • Victorian Government Department of Health.(2011). The Victorian drug statistics handbook: Patterns of drug use and related harm in Victoria for the period July 2008 to June 2009. Melbourne: Author.
  • Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review, 18, 63–73.
  • Wallace, C., Galloway, T., McKetin, R., Kelly, E., & Leary, J. (2009). Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug and Alcohol Review, 28, 592–599.
  • Wright, S., & Klee, H. (1999). A profile of amphetamine users who present to treatment services and do not return. Drugs: Education, Prevention and Policy, 6(2), 227–241.
  • Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., Iguchi, M., (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13(2), 181–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.